Vise Technologies Inc. bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,609 shares of the company’s stock, valued at approximately $1,743,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Royal Bank of Canada boosted its holdings in Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after acquiring an additional 95,409 shares in the last quarter. AQR Capital Management LLC raised its holdings in Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares in the last quarter. Empowered Funds LLC raised its holdings in Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares in the last quarter. First Trust Advisors LP lifted its position in shares of Astera Labs by 102.0% in the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after purchasing an additional 56,952 shares during the period. Finally, Brown Advisory Inc. boosted its stake in shares of Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after purchasing an additional 1,977 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.
Astera Labs Price Performance
NASDAQ:ALAB opened at $284.97 on Friday. The firm’s 50-day moving average price is $352.70 and its 200-day moving average price is $244.92. The company has a market capitalization of $49.44 billion, a PE ratio of 141.07 and a beta of 3.84. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48.
Insider Buying and Selling at Astera Labs
In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on the stock. Stifel Nicolaus boosted their price target on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. TD Cowen cut their price objective on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday, August 5th. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price on the stock in a report on Monday, August 17th. JPMorgan Chase & Co. increased their target price on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, Rothschild & Co Redburn initiated coverage on Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $333.00.
Read Our Latest Research Report on ALAB
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
